Protocol No.: EA4151

Title
A Randomized Phase III Trial of Consolidation with Autologous Hematopoietic Cell Transplantation Followed by Maintenance Rituximab vs. Maintenance Rituximab Alone for Patients with Mantle Cell Lymphoma In Minimal Residual Disease-Negative First Complete Remission
Principal Investigator
Shafi, Sumaira; Veltri, Lauren
Phase
III
Age Group
Adult
Applicable Disease Site
Lymphoma
Participating Institutions
Camden Clark Memorial Hospital
Mary Babb Randolph Cancer Center
Contacts
Sylvia McEwuen, RN, CCRC
Study Coordinator/Research Nurse
Phone: +1 304-293-1683
Christa Boice, RN
Research Nurse
Phone: +1 304-420-7132

View on ClinicalTrials.gov